Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-86.36%
operating margin TTM
-96.79%
revenue TTM
1.22 Million
revenue per share TTM
0.37$
valuation ratios | |
|---|---|
| pe ratio | -0.07 |
| peg ratio | -0.00 |
| price to book ratio | 0.31 |
| price to sales ratio | 0.37 |
| enterprise value multiple | -0.45 |
| price fair value | 0.31 |
profitability ratios | |
|---|---|
| gross profit margin | 68.19% |
| operating profit margin | -96.79% |
| pretax profit margin | -85.56% |
| net profit margin | -86.36% |
| return on assets | -125.86% |
| return on equity | -179.83% |
| return on capital employed | -498.11% |
liquidity ratio | |
|---|---|
| current ratio | 1.33 |
| quick ratio | 0.60 |
| cash ratio | 0.18 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 411.41 |
| operating cycle | 471.36 |
| days of payables outstanding | 295.17 |
| cash conversion cycle | 176.19 |
| receivables turnover | 6.09 |
| payables turnover | 1.24 |
| inventory turnover | 0.89 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.03 |
| debt equity ratio | 0.13 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.11 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -32.45 |
cash flow ratios | |
|---|---|
| free cash flow per share | -12.18 |
| cash per share | 1.46 |
| operating cash flow per share | -12.18 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -32.45 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time ReShape Lifesciences Inc. (NASDAQ:RSLS) reported earnings?
ReShape Lifesciences Inc. (RSLS) published its most recent earnings results on 14-11-2024.
What is ReShape Lifesciences Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. ReShape Lifesciences Inc. (NASDAQ:RSLS)'s trailing twelve months ROE is -179.83%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. ReShape Lifesciences Inc. (RSLS) currently has a ROA of -125.86%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did RSLS's net profit margin stand at?
RSLS reported a profit margin of -86.36% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is RSLS's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.33 in the most recent quarter. The quick ratio stood at 0.60, with a Debt/Eq ratio of 0.13.